BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 1-Year High – Time to Buy?

BlackRock Capital Allocation Term Trust (NYSE:BCAT) shares reached a new 52-week high on Monday . The company traded as high as $16.05 and last traded at $16.0650, with a volume of 651691 shares. The stock had previously closed at $15.82.

BlackRock Capital Allocation Term Trust Trading Up 1.5%

The company has a fifty day moving average price of $15.48 and a two-hundred day moving average price of $14.93.

BlackRock Capital Allocation Term Trust Dividend Announcement

The business also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be paid a dividend of $0.2542 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 19.0%.

Institutional Trading of BlackRock Capital Allocation Term Trust

Large investors have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. raised its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after acquiring an additional 1,582 shares during the period. N.E.W. Advisory Services LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 100.0% in the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after purchasing an additional 1,200 shares during the period. McIlrath & Eck LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 169.6% in the first quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after purchasing an additional 1,969 shares during the period. Parallel Advisors LLC acquired a new stake in BlackRock Capital Allocation Term Trust during the third quarter worth about $47,000. Finally, Brown Brothers Harriman & Co. increased its position in BlackRock Capital Allocation Term Trust by 450.0% during the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock worth $81,000 after purchasing an additional 4,500 shares during the last quarter. 36.12% of the stock is currently owned by hedge funds and other institutional investors.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.